However, in the setting of cardiac disease with decreased baseline Cx43 expression, dyssynchronous activation with its attendant effects on gap junction remodeling may further exacerbate arrhythmic complications and worsen cardiac performance. The gene discussed is GJA1; the disease is heart disorder.